<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-901</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>М2-ПОДОБНЫЕ МАКРОФАГИ КАК ПОТЕНЦИАЛЬНЫЕ КАНДИДАТЫ В ЛЕЧЕНИИ ПОСЛЕДСТВИЙ ЦЕРЕБРАЛЬНОГО ИНСУЛЬТА</article-title><trans-title-group xml:lang="en"><trans-title>M2-LIKE MACROPHAGES ARE POTENTIAL CANDIDATES FOR BRAIN STROKE OUTCOMES' TREATMENT</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Морозов</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Morozov</surname><given-names>S. A.</given-names></name></name-alternatives><email xlink:type="simple">El-gorra@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Томаш</surname><given-names>Г. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tomash</surname><given-names>G. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шевела</surname><given-names>Е. Я.</given-names></name><name name-style="western" xml:lang="en"><surname>Shevela</surname><given-names>E. Ya.</given-names></name></name-alternatives><email xlink:type="simple">shevelak@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сахно</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sakhno</surname><given-names>L. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смык</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smyk</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">anna-v-smyk@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Старостина</surname><given-names>Н. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Starostina</surname><given-names>N. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Останин</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ostanin</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черных</surname><given-names>Е. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernykh</surname><given-names>E. R.</given-names></name></name-alternatives><email xlink:type="simple">bmt-novosibirsk@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ клинической иммунологии СО РАМН; ГБОУ ВПО НГМУ Росздрава</institution></aff><aff xml:lang="en"><institution>Research Institute of Clinical Immunology SD RAMS</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГКБ № 1</institution></aff><aff xml:lang="en"><institution>Research Institute of Clinical Immunology SD RAMS</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>НИИ клинической иммунологии СО РАМН</institution></aff><aff xml:lang="en"><institution>Research Institute of Clinical Immunology SD RAMS</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>28</day><month>05</month><year>2012</year></pub-date><volume>0</volume><issue>3(2)</issue><fpage>125</fpage><lpage>128</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Морозов С.А., Томаш Г.В., Шевела Е.Я., Сахно Л.В., Смык А.В., Старостина Н.М., Останин А.А., Черных Е.Р., 2012</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="ru">Морозов С.А., Томаш Г.В., Шевела Е.Я., Сахно Л.В., Смык А.В., Старостина Н.М., Останин А.А., Черных Е.Р.</copyright-holder><copyright-holder xml:lang="en">Morozov S.A., Tomash G.V., Shevela E.Y., Sakhno L.V., Smyk A.V., Starostina N.M., Ostanin A.A., Chernykh E.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/901">https://www.actabiomedica.ru/jour/article/view/901</self-uri><abstract><p>Целью настоящего исследования стала оценка безопасности и эффективности in vitro генерированных М2-подобных макрофагов в лечении больных с ишемическим и геморрагическим инсультом в восстановительном и резидуальном периоде. Однократное эндолюмбальное введение аутологичных макрофагов в средней дозе 17,9 х 106 клеток проведено 13 пациентам с ишемическим (n = 10) и геморрагическим (n = 3) инсультом. Через 6 месяцев после введения клеток у всех пациентов отмечалось клиническое улучшение. Отмечалось достоверное снижение балла NIHS с 8,6 ± 1,06 до 4,4 ± 0,55 (p = 0,0008), у части пациентов регрессировали нарушения чувствительности наблюдалось улучшение когнитивных функций и качество жизни. Таким образом, показана возможность генерации М2-подобных макрофагов у пациентов с инсультом, эндолюмбальное введение клеток безопасно и не вызывает выраженных побочных реакций и осложнений и, по предварительным данным, позволяет добиться улучшения двигательных и когнитивных функций.</p></abstract><trans-abstract xml:lang="en"><p>The safety and effectiveness of in vitro generated M2-like macrophages for treatment of patients with ischemic and hemorrhagic brain stroke in reparative and residual periods has been evaluated. A single endolumbar administration of autologous M2-like macrophages in the mean dose of 17,9 х 106 cells was conducted in 13 patients with ischemic (n = 10) and hemorrhagic (n = 3) brain stroke. At 6 months after cells administration all the patients had clinical Improvement. NIHS score decreased from 8,6 ± 1,06 to 4,4 ± 0.55 (p = 0,0008), several patients showed the decrease of sensitiveness impairments, improvement of cognitive functions and enhanced quality of life. Thus, we demonstrated an ability of generation M2-like macrophages from patients with brain stroke. Endolumbar administration of these cells was safe andi didn't cause severe adverse effects and complications andi — in preliminary data — improvedi motional and cognitive functions.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инсульт</kwd><kwd>М2-подобные макрофаги</kwd></kwd-group><kwd-group xml:lang="en"><kwd>brain stroke</kwd><kwd>M2-like macrophages</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Asher R.A., Morgenstern D.A., Moon L.D., Fawcett J.W. Chondroitin sulphate proteoglycans: inhibitory components of the glial scar // Prog Brain Res. - 2001. - Vol. 132. - P. 611-619.</mixed-citation><mixed-citation xml:lang="en">Asher R.A., Morgenstern D.A., Moon L.D., Fawcett J.W. Chondroitin sulphate proteoglycans: inhibitory components of the glial scar // Prog Brain Res. - 2001. - Vol. 132. - P. 611-619.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chernykh E.R., Kafanova M.Yu., Shevela E.Ya., Adonina E.I. et al. Autologous M2-like macrophage applications in children with cerebral palsy // Cell Ther. Transplant. - 2011. - Vol. 3. - P. 12-14.</mixed-citation><mixed-citation xml:lang="en">Chernykh E.R., Kafanova M.Yu., Shevela E.Ya., Adonina E.I. et al. Autologous M2-like macrophage applications in children with cerebral palsy // Cell Ther. Transplant. - 2011. - Vol. 3. - P. 12-14.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chernykh E.R., Shevela E.Y., Sakhno L.V., Tikhonova M.A. et al. The generation and properties of human M2-like macrophages: potential candidates for CNS repair? // Cellular Therapy and Transplantation. - 2010. - Vol. 2. - P. 20-23.</mixed-citation><mixed-citation xml:lang="en">Chernykh E.R., Shevela E.Y., Sakhno L.V., Tikhonova M.A. et al. The generation and properties of human M2-like macrophages: potential candidates for CNS repair? // Cellular Therapy and Transplantation. - 2010. - Vol. 2. - P. 20-23.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Domeniconi M., Cao Z., Spencer T., Sivasankaran R. et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth // Neuron. - 2002. - Vol. 35. - P. 283-290.</mixed-citation><mixed-citation xml:lang="en">Domeniconi M., Cao Z., Spencer T., Sivasankaran R. et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth // Neuron. - 2002. - Vol. 35. - P. 283-290.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Fitch M.T., Silver J. Activated macrophages and the blood-brain barrier: inflammation after CNS injuryleads to increases in putative inhibitory molecules // Exp Neurol. - 1997. - Vol. 148. - P. 587-603.</mixed-citation><mixed-citation xml:lang="en">Fitch M.T., Silver J. Activated macrophages and the blood-brain barrier: inflammation after CNS injuryleads to increases in putative inhibitory molecules // Exp Neurol. - 1997. - Vol. 148. - P. 587-603.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Freire-de-Lima C.G., Xiao Y.Q., Gardai S.J., Bratton D.L. et al. Apoptotic cells, through transforming growth factor-ß, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages // J Biol Chem. - 2006. - Vol. 281. - P. 38376-38384.</mixed-citation><mixed-citation xml:lang="en">Freire-de-Lima C.G., Xiao Y.Q., Gardai S.J., Bratton D.L. et al. Apoptotic cells, through transforming growth factor-ß, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages // J Biol Chem. - 2006. - Vol. 281. - P. 38376-38384.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Golpon H.A., Fadok V.A., Taraseviciene-Stewart L. Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth // The FASEB Journal. - 2004. - Vol. 18. -P. 1716-1718.</mixed-citation><mixed-citation xml:lang="en">Golpon H.A., Fadok V.A., Taraseviciene-Stewart L. Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth // The FASEB Journal. - 2004. - Vol. 18. -P. 1716-1718.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity // Nat. Rev. Immunol. - 2005. -Vol. 5. - P. 953-964.</mixed-citation><mixed-citation xml:lang="en">Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity // Nat. Rev. Immunol. - 2005. -Vol. 5. - P. 953-964.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K. et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord // J. Neurosci. - 2009. - Vol. 29. -P. 13435-13444.</mixed-citation><mixed-citation xml:lang="en">Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K. et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord // J. Neurosci. - 2009. - Vol. 29. -P. 13435-13444.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mantovani A., Sica A., Sozzani S., Allavena P. et al. The chemokine system in diverse forms of macrophage activation and polarization // Trends Immunol. - 2004. - Vol. 25. - P. 677-686.</mixed-citation><mixed-citation xml:lang="en">Mantovani A., Sica A., Sozzani S., Allavena P. et al. The chemokine system in diverse forms of macrophage activation and polarization // Trends Immunol. - 2004. - Vol. 25. - P. 677-686.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">McPhail L.T., Stirling D.P., Tetzlaff W., Kwiecien J.M. et al. The contribution of activated phagocytes and myelin degeneration to axonal retraction/dieback following spinal cord injury // Eur. J. Neurosci. - 2004. - Vol. 20. - P. 1984-1994.</mixed-citation><mixed-citation xml:lang="en">McPhail L.T., Stirling D.P., Tetzlaff W., Kwiecien J.M. et al. The contribution of activated phagocytes and myelin degeneration to axonal retraction/dieback following spinal cord injury // Eur. J. Neurosci. - 2004. - Vol. 20. - P. 1984-1994.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mosser D.M. The many faces of macrophage activation // J. Leukocyte Biol. - 2003. - Vol. 73. -P. 209-212.</mixed-citation><mixed-citation xml:lang="en">Mosser D.M. The many faces of macrophage activation // J. Leukocyte Biol. - 2003. - Vol. 73. -P. 209-212.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Shechter R., London A., Varol C., Raposo C. et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice // PLoS Medicine. -2009. - Vol. 6. - P. 1-16.</mixed-citation><mixed-citation xml:lang="en">Shechter R., London A., Varol C., Raposo C. et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice // PLoS Medicine. -2009. - Vol. 6. - P. 1-16.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ziv Y., Avidan H., Pluchino S., Martino G. et al. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury // Proc. Natl. Acad. Sci. USA. -2006. - Vol. 103. - P. 13174-13179.</mixed-citation><mixed-citation xml:lang="en">Ziv Y., Avidan H., Pluchino S., Martino G. et al. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury // Proc. Natl. Acad. Sci. USA. -2006. - Vol. 103. - P. 13174-13179.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
